Compare PRGO & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRGO | IIPR |
|---|---|---|
| Founded | 1887 | 2016 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2013 | 2016 |
| Metric | PRGO | IIPR |
|---|---|---|
| Price | $14.08 | $51.60 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | $16.50 | ★ $64.50 |
| AVG Volume (30 Days) | ★ 2.4M | 248.3K |
| Earning Date | 11-04-2026 | 11-02-2026 |
| Dividend Yield | 7.86% | ★ 14.43% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.39 |
| Revenue | $800,000.00 | ★ $265,955,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.74 | $3.98 |
| P/E Ratio | ★ N/A | $22.09 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.23 | $44.58 |
| 52 Week High | $22.65 | $65.38 |
| Indicator | PRGO | IIPR |
|---|---|---|
| Relative Strength Index (RSI) | 57.97 | 26.09 |
| Support Level | $13.37 | $48.51 |
| Resistance Level | $15.06 | $51.68 |
| Average True Range (ATR) | 0.61 | 1.02 |
| MACD | 0.02 | -0.36 |
| Stochastic Oscillator | 62.60 | 0.34 |
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Innovative Industrial Properties Inc is a real estate investment trust focused on the acquisition, ownership and management of specialized industrial and commercial properties in the United States. Its properties are prominently leased to state-licensed operators for their regulated cannabis facilities. The company conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by its Operating Partnership, directly or through subsidiaries. Its segments are: Cannabis Portfolio and Life Science Portfolio, with the majority of revenue coming from the Cannabis Portfolio segment, which involves acquiring, developing, and leasing real estate to regulated cannabis operators on long-term triple-net leases.